Fundraising for treatment
High-risk neuroblastoma is an aggressive cancer with high rates of relapse. At relapse, the chance of survival is extremely low. Some families affected by high-risk neuroblastoma will choose to fundraise for access to treatment that is not available through the NHS, to try to get their child back into remission, or to try to keep their cancer away. Solving Kids' Cancer UK fully supports parent choice and therefore, helps families with fundraising campaigns for recognised and approved clinical trials or treatments. In the first instance, we always encourage families to discuss their child's treatment with their child's UK consultant.
Treatment options outside of the UK can often cost hundreds of thousands of pounds and raising this level of funds is a huge additional burden on families. This is why supporting families to set up and oversee their fundraising campaign is an important aspect of our support provision. Solving Kids' Cancer UK also helps families with the challenges and logistics of accessing treatment overseas.
If you'd like more information about fundraising campaigns for access to treatment, contact us on 0207 284 0800 or email fundraising@solvingkidscancer.org.uk.
Current fundraising campaigns
We are currently supporting a number of children and families to fundraise for access to treatment. Click through to learn more about each child's story and to make a donation.
Donations made to children's fundraising campaigns will go towards supporting the child and family to access treatment and with any pastoral needs. If a child and family no longer needs the funds or a child is in remission five years post the end of successful treatment, the funds will be used to support other children and families affected by neuroblastoma through Solving Kids' Cancer UK's activities. If you'd like more information about fundraising for access to treatment generally, or about any of the children's fundraising campaigns below, contact us on 0207 284 0800 or email fundraising@solvingkidscancer.org.uk.
Thank you for supporting children and families!
Annabel's campaign
Annabel is a five-year-old who dreams of being a nurse when she grows up. Her parents are asking for your help to make this a reality and give Annabel her happily ever after. In April 2023, Annabel was diagnosed with high-risk neuroblastoma. Her family are urgently fundraising £105,000 so she can enrol on the DFMO study in Penn State by November.
Read moreAmelia's campaign
Amelia is a kind and caring six-year-old. Her favourite colours are pink and purple, and she loves exploring new places. In September 2020, Amelia was diagnosed with high-risk neuroblastoma. After completing treatment in August 2022 and enjoying life, devastatingly scans showed her cancer had returned in April 2024.
Read moreFreya's campaign
Freya is seven years old and always has a smile on her face. She loves nothing more than spending time with her identical twin Alice. In December 2022, Freya was diagnosed with stage 4 high-risk neuroblastoma. After completing 15 months of frontline treatment, end-of-treatment scans showed Freya had relapsed.
Read moreRio's campaign
Rio is a happy, playful and energetic three-year-old who adores cars and spending time with his big sister Lillyrose! In August 2023, Rio was diagnosed with stage 4 high-risk neuroblastoma.
Read moreFlora's new campaign
Flora is an energetic, outdoor-loving five-year-old from East Lothian, Scotland. Her family are continuing to fundraise, after Flora sadly relapsed in September 2023, so she can enrol on the bivalent vaccine clinical trial in New York.
Read moreLeonardo's campaign
Leonardo is a five-year-old from London who loves superheroes and motorcycles. In May 2022, Leonardo was diagnosed with high-risk neuroblastoma and he completed frontline treatment in July 2023 but sadly his disease progressed.
Read moreArchie's campaign
Four-year-old Archie loves Hot Wheels and Paw Patrol. In July 2022, Archie was diagnosed with high-risk neuroblastoma. His family are fundraising £154,000 so he can enrol on the DFMO study in Charlotte once he finishes his frontline treatment in October. This trial is currently not available on the NHS.
Read moreTeddy's campaign
Teddy is a four-year-old from West Sussex who is obsessed with trains! In July 2022, Teddy was diagnosed with high-risk neuroblastoma. Thanks to your incredible support, in February 2024 Teddy enrolled on the DFMO Study at the Penn State Children's Hospital.
Read moreArianna's campaign
Arianna is a beautiful, funny and kind-hearted eight-year-old, who loves dressing up! In November 2021, she was diagnosed with high-risk neuroblastoma. Arianna is currently enrolled on the bivalent vaccine clinical trial in New York, thanks to an incredible community of support for her campaign.
Read moreJessica's campaign
Jessica is the sweetest, kindest four-year-old who loves animals, all things Peppa Pig and playing with her cousin, Maeve. Jessica has high-risk neuroblastoma.
Read moreDulcie's campaign
Dulcie is a beautiful and brave seven-year-old from Shropshire. She loves My Little Pony, all Disney princesses, rainbows and everything that sparkles! Dulcie was diagnosed with high-risk neuroblastoma in December 2021.
Read moreKayla's campaign
Kayla is a very happy and lively six-year-old from Norwich. She loves Minnie Mouse, Frozen, Peppa Pig and all things pink! Kayla was diagnosed with high-risk neuroblastoma and in November 2022, her end-of-treatment scans showed disease progression.
Read moreEden's campaign
Eden is full of life, very cheeky and loved by so many people. Eden is currently enrolled on the bivalent vaccine clinical trial in New York, thanks to an incredible community of support for Eden’s campaign.
Read moreKatie Rose's campaign
Katie Rose is a fun-loving, quick-witted, brave 13-year-old girl, who loves making slime, playing Fortnite on her PlayStation, Roblox and Toca Life World and jumping on her trampoline. In March 2018, Katie Rose was diagnosed with high-risk neuroblastoma.
Read moreKira's campaign
Kira’s 20 years old and has been fighting neuroblastoma since she was 11. She’s faced years of gruelling treatment to try to get rid of her disease and has relapsed eight times.
Read moreMaysaa's campaign
Maysaa is six years old and loves strawberries, unicorns and rainbows. Maysaa enrolled on the DFMO study in Charlotte in August 2022 to continue her treatment, which was made possible by the community of supporters who helped raise the £106,000 needed.
Read morePoppy's campaign
Eight-year-old Poppy loves playing in the park with her friends and her brother. Poppy completed her frontline treatment in October 2022 and scans continue to show no evidence of active disease.
Read moreAshlee's campaign
Ashlee is 17 years old and loves music, fashion and her dog, Angel. Ashlee completed the bivalent vaccine clinical trial in December 2021, thanks to the amazing support her campaign received to raise the £239,000 needed.
Read more